Caplin Point Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
CAPLIPOINT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Caplin Point Laboratories has informed the stock exchanges that its trading window will remain closed starting January 1, 2026. This is a mandatory compliance measure under SEBI's Insider Trading Regulations. The closure is linked to the finalisation of unaudited financial results for the quarter ending December 31, 2025 (Q3 FY26). The trading window will reopen 48 hours after these quarterly results are officially announced to the exchanges. The intimation was signed by Venkatram G, General Counsel & Company Secretary.
This is a routine regulatory filing and has no direct impact on the stock price. Insiders such as directors and key employees are restricted from trading in the company's shares until 48 hours after Q3 FY26 results are declared, which signals that the quarterly earnings announcement is imminent.